CYP20A1

Across TCGA pan-cancer cohorts, CYP20A1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CYP20A1 data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CYP20A1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CYP20A1 expression acts as an unfavorable survival marker.

COAD, BLCA, and UCEC are the cancer types where CYP20A1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	III,IV	0.133	0.783	<.001	15	view →
BLCA	OS	Median	IV	0.089	0.599	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CYP20A1–COAD (OS)

Open the COAD breakdown →